AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2026
Mar 3, 2026
34395_dirs_2026-03-03_6e2f284b-2a4d-4782-b02d-bd55deb746a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2026-03-01-05:00
Reporting Person: Plummer Nicholas (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-01-05:00 | Common Stock | F | 5867 | $0.213 | Disposed | 414270 | Direct |
Footnotes
F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.
More from VOLITIONRX LTD
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1